Janssen-Cilag announces new data from MAIC analysis of IMBRUVICA at EHA Congress ($155.26, 0.00)
Trading halted in Lonza Group pending news release (CHF 568.00, 0.00)
StreetAccount Summary - Trading higher/lower: EU mid-morning
Energy, Basic Resources and HealthCare lead; Insurance, Travel & Leisure and Real Estate lag:
Lonza Group Q1 qualitative update: strong CDMO performance (CHF 571.20, 0.00)
Powered by FactSet Research Systems Inc.